Standard coagulation assays alone are not sufficient to exclude surgically relevant rivaroxaban plasma concentrations

BACKGROUND: While mainly larger hospitals have introduced routine anti-Xa assays for rivaroxaban (RXA), these are not readily available to smaller hospitals often relying on routine coagulation tests such as prothrombin time (PT) and activated partial thromboplastin time (aPTT). The aim of our study...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaserer, Alexander, Schedler, Andreas, Seifert, Burkhardt, Spahn, Donat R., Studt, Jan-Dirk, Stein, Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6864962/
https://www.ncbi.nlm.nih.gov/pubmed/31832179
http://dx.doi.org/10.1186/s13741-019-0128-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6864962/
https://www.ncbi.nlm.nih.gov/pubmed/31832179
http://dx.doi.org/10.1186/s13741-019-0128-9

Ejemplares similares